Lipopolysaccharide: An endotoxin or an exogenous hormone?

Clinical Infectious Diseases

Volumn 41, Issue SUPPL. 7, 2005, Pages

  Marshall, John C ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; CALCITONIN; CARRIER PROTEIN; CLOSTRIDIUM TOXIN; DNA; EXOTOXIN; GLUCAGON; HORMONE; HYDROCORTISONE; INSULIN; PARATHYROID HORMONE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR;

ANIMAL MODEL; BACTERIAL INFECTION; CONFERENCE PAPER; CONTROLLED STUDY; ENDOSYMBIOSIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HORMONE RELEASE; HUMAN; IMMUNE RESPONSE; INTESTINE FLORA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; TOXIN ANALYSIS;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTOXINS; EVOLUTION; GASTROINTESTINAL TRACT; GRAM-NEGATIVE BACTERIA; HOMEOSTASIS; HORMONES; HUMANS; IMMUNITY, NATURAL; LIPOPOLYSACCHARIDES; SEPSIS; SIGNAL TRANSDUCTION; SYMBIOSIS;

EID: 27744570445     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/432000     Document Type: Conference Paper

References (105)

1. Lederberg J. Infectious history. Science 2000; 288:287-93.
2. Dyall SD, Brown MT, Johnson PJ. Ancient invasions: from endosymbionts to organelles. Science 2004; 304:253-7.
3. Gray MW, Burger G, Lang BF. Mitochondrial evolution. Science 1999; 283:1476-81.
4. Bauer J, Hiltbrunner A, Kessler F. Molecular biology of chloroplast biogenesis: gene expression, protein import, and intraorganellar sorting. Cell Mol Life Sci 2001; 58:420-33.
5. Veldhuyzen van Zanten SJ, Sherman PM. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. CMAJ 1994; 150:177-85.
6. Kalayoglu MV, Libby P, Byrne GI. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA 2002; 288:2724-31.
7. Dean M, Carrington M, O'Brien SJ. Balanced polymorphism selected by genetic versus infectious human disease. Annu Rev Genomics Hum Genet 2002; 3:263-92.
8. Ochman H, Moran NA. Genes lost and genes found: evolution of bacterial pathogenesis and symbiosis. Science 2001; 292:1096-8.
9. Stark PL, Lee A. The microbial ecology of the large bowel of breast fed and formula fed infants during the first year of life. J Med Microbiol 1982; 15:189-203.
10. Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977; 31:107-33.
11. Sonnenburg JL, Angenent LT, Gordon JI. Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? Nat Immunol 2004; 5:569-73.
12. Rawls JF, Samuel BS, Gordon JI. Gnotobiotic zebrafish reveal evolutionarily conserved responses to the gut microbiota. Proc Natl Acad Sci USA 2004; 101:4596-601.
13. Mutch DM, Simmering R, Donnicola D, et al. Impact of commensal microbiota on murine gastrointestinal tract gene ontologies. Physiol Genomics 2004; 19:22-31.
14. Alam M, Midtvedt T, Uribe A. Differential cell kinetics in the ileum and colon of germfree rats. Scand J Gastroenterol 1994; 29:445-51.
15. Uribe A, Alam M, Johansson O, Midtvedt T, Theodorsson E. Microflora modulates endocrine cells in the gastrointestinal mucosa of the rat. Gastroenterology 1994; 107:1259-69.
16. Stappenback TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA 2002; 99:15451-5.
17. Freitas M, Axelsson LG, Cayuela C, Midtvedt T, Trugnan G. Microbial-host interactions specifically control the glycosylation pattern in intestinal mouse mucosa. Histochem Cell Biol 2002; 118:149-61.
18. Husebye E, Hellstrom PM, Sundler F, Chen J, Midtvedt T. Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol 2001; 280: G368-80.
19. Okada M, Bothin C, Kanazawa K, Midtvedt T. Experimental study of the influence of intestinal flora on the healing of intestinal anastomoses. Br J Surg 1999; 86:961-5.
20. Dubos RJ, Schaedler RW. The effect of the intestinal flora on the growth rate of mice, and their susceptibility to experimental infections. J Exp Med 1960; 111:407-17.
21. Schaedler RW, Dubos RJ. The fecal flora of various strains of mice: its bearing on their susceptibility to endotoxin. J Exp Med 1962; 115:1149-59.
22. Hudault S, Guignol J, Servin AL. Escherichia coli strains colonising the gastrointestinal tract protect germfree mice against Salmonella typhimurium infection. Gut 2001; 49:47-55.
23. Pabst R, Geist M, Rothkotter HJ, Fritz FJ. Postnatal development and lymphocyte production of jejunal and ileal Payer's patches in normal and gnotobiotic pigs. Immunology 1988; 64:539-44.
24. Rhee KJ, Sethupathi P, Driks A, Lanning DK, Knight KL. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. J Immunol 2004; 172:1118-24.
25. Maeda Y, Noda S, Tanaka K, et al. The failure of oral tolerance induction is functionally coupled to the absence of T cells in Peyer's patches under germfree conditions. Immunobiology 2001; 204:442-57.
26. Velders GA, van Os R, Hagoort H, et al. Reduced stem cell mobilization in mice receiving antibiotic modulation of the intestinal flora: involvement of endotoxins as cofactors in mobilization. Blood 2004; 103:340-6.
27. Nicaise P, Gleizes A, Sandre C, et al. The intestinal microflora regulates cytokine production positively in spleen-derived macrophages but negatively in bone marrow-derived macrophages. Eur Cytokine Netw 1999; 10:365-72.
28. Xu J, Gordon JI. Inaugural article: honor thy symbionts. Proc Natl Acad Sci USA 2003; 100:10,452-9.
29. Xu J, Bjursell MK, Himrod J, et al. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 2003; 299:2074-6.
30. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291:881-4.
31. Freitas M, Cayuela C, Anatoine JM, Piller F, Sapin C, Trugnan G. A heat labile soluble factor from Bacteroides thetaiotaomicron VPI-5482 specifically increases the galactosylation pattern of HT29-MTX cells. Cell Microbiol 2001; 3:289-300.
32. Kelly D, Campbell JI, King TP, et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 2004; 5:14-6.
33. Neish AS, Gewirtz AT, Zeng H, et al. Prokaryotic regulation of epithelial responses by inhibition of IkappaBa ubiquitination. Science 2000; 289:1560-3.
34. Wernegreen JJ. Genome evolution in bacterial endosymbionts of insects. Nat Rev Genet 2002; 3:850-61.
35. Islas S, Becerra A, Luisi PL, Lazcano A. Comparative genomics and the gene complement of a minimal cell. Orig Life Evol Biosph 2004; 34:243-56.
36. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001; 292:1115-8.
37. Lang BF, Gray MW, Burger G. Mitochondrial genome evolution and the origin of eukaryotes. Annu Rev Genet 1999; 33:351-97.
38. Tishkoff SA, Varkonyi R, Cahinhinan N, et al. Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science 2001; 293:455-62.
39. Stedman TL, ed. Stedman's medical dictionary. 27th ed. New York: Lippincott Williams & Wilkins, 2000.
40. Soria B, Quesada I, Ropero AB, Pertusa JA, Martin F, Nadal A. Novel players in pancreatic islet signaling: from membrane receptors to nuclear channels. Diabetes 2004;53(Suppl 1):S86-91.
41. Itoi K, Jiang YQ, Iwasaki Y, Watson SJ. Regulatory mechanisms of corticotropin-releasing hormone and vasopressin gene expression in the hypothalamus. J Neuroendocrinol 2004; 16:348-55.
42. Palha JA. Transthyretin as a thyroid hormone carrier: function revisited. Clin Chem Lab Med 2002; 40:1292-300.
43. Breuner CW, Orchinik M. Plasma binding proteins as mediators of corticosteroid action in vertebrates. J Endocrinol 2002; 175:99-112.
44. Garrel DR. Corticosteroid-binding globulin during inflammation and burn injury: nutritional modulation and clinical implications. Horm Res 1996; 45:245-51.
45. Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004; 350:1629-38.
46. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001; 414:799-806.
47. Herrlich P. Cross-talk between glucocorticoid receptor and AP-1. Oncogene 2001; 20:2465-75.
48. Sandvig K, van Deurs B. Transport of protein toxins into cells: pathways used by ricin, cholera toxin, and Shiga toxin. FEBS Lett 2002; 529:49-53.
49. Sack DA, Sack RB, Nair GB, Siddique AK. Cholera. Lancet 2004; 363:223-33.
50. Just I, Hofmann F, Genth H, Gerhard R. Bacterial protein toxins inhibiting low-molecular-mass GTP-binding proteins. Int J Med Microbiol 2001; 291:243-50.
51. Llewelyn M, Cohen J. Superantigens: microbial agents that corrupt immunity. Lancet Infect Dis 2002; 2:156-62.
52. Chesnokova V, Melmed S. Minireview: neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. Endocrinology 2002; 143:1571-4.
53. Alexander C, Rietschel ET. Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 2001; 7:167-202.
54. Opal SM, Scannon PJ, Vincent JL, et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 1999; 180:1584-9.
55. Roumen RMH, Frieling JTM, van Tits HW, van der Vliet JA, Goris RJ. Endotoxemia after major vascular operations. J Vase Surg 1993; 18:853-7.
56. Marshall JC, Foster D, Vincent JL, et al. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 2004; 190:527-34.
57. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999; 115:829-35.
58. Nahum A, Hoyt J, Schmitz L, Moody J, Shapiro R, Marini JJ. Effect of mechanical ventilation strategy on dissemination of intratracheally instilled Escherichia coli in dogs. Crit Care Med 1997; 25:1733-43.
59. Gioannini TL, Teghanemt A, Zarember KA, Weiss JP. Regulation of interactions of endotoxin with host cells. J Endotoxin Res 2003; 9:401-8.
60. Zhao B, Bowden RAS, Stavchansky SA, Bowman PD. Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays. Am J Physiol Cell Physiol 2001; 281: C1587-95.
61. Fessler MB, Malcolm KC, Duncan MW, Worthen GS. A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase. J Biol Chem 2002; 277:31,291-302.
62. Brock-Utne JG, Gaffin SL, Wells MT, et al. Endotoxaemia in exhausted runners after a long-distance race. S Afr Med J 1988; 73:533-6.
63. Ashton T, Young IS, Davison GW, et al. Exercise-induced endotoxemia: the effect of ascorbic acid supplementation. Free Radic Biol Med 2003; 35:284-91.
64. Ravindranath T, Yoshioka T, Goto M, et al. Endotoxemia following enteral refeeding in children. Clin Pediatr (Phila) 1997; 36:523-8.
65. Buttenschoen K, Berger D, Strecker W, et al. Association of endotoxemia and production of antibodies against endotoxins after multiple injuries. J Trauma 2000; 48:918-23.
66. Buttenschoen K, Fleischmann W, Haupt U, Kinzl L, Buttenschoen DC. Translocation of endotoxin and acute-phase proteins in malleolar fractures. J Trauma 2000; 48:241-5.
67. Berger D, Boelke E, Stanescu A, et al. Endotoxemia and mediator release during colonoscopy. Endoscopy 1995; 27:671-5.
68. Vreugdenhil AC, Dentener MA, Snoek AM, Greve JW, Buurman WA. Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response. J Immunol 1999; 163:2792-8.
69. Gioannini TL, Zhang D, Teghanemt A, Weiss JP. An essential role for albumin in the interaction of endotoxin with lipopolysaccharide-binding protein and sCD14 and resultant cell activation. J Biol Chem 2002; 277:47,818-25.
70. Heumann D, Roger T. Initial responses to endotoxins and Gram-negative bacteria. Clin Chim Acta 2002; 323:59-72.
71. Thomas CJ, Kapoor M, Sharma S, et al. Evidence of a trimolecular complex involving LPS, LPS binding protein, and soluble CD 14 as an effector of LPS response. FEBS Lett 2002; 531:184-8.
72. Thompson PA, Tobias PS, Viriyakosol S, Kirldand TN, Kitchens RL. Lipopolysaccharide (LPS)-binding protein inhibits responses to cell-bound LPS. J Biol Chem 2003; 278:28,367-71.
73. Triantafilou M, Brandenburg K, Kusumoto S, et al. Combinational clustering of receptors following stimulation by bacterial products determines lipopolysaccharide responses. Biochem J 2004; 381:527-36.
74. Kennedy MN, Mullen GE, Leifer CA, et al. A complex of soluble MD-2 and lipopolysaccharide serves as an activating ligand for toll-like receptor 4. J Biol Chem 2004; 279:34,698-704.
75. Gioannini TL, Teghanemt A, Zhang D, et al. Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc Natl Acad Sci USA 2004; 101:4186-91.
76. Gruber A, Mancek M, Wagner H, Kirschning CJ, Jerala R. Structural model of MD-2 and functional role of its basic amino acid clusters involved in cellular lipopolysaccharide recognition. J Biol Chem 2004; 279:28475-82.
77. Dunzendorfer S, Lee HK, Soldau K, Tobias PS. TLR4 is the signaling but not the lipopolysaccharide uptake receptor. J Immunol 2004; 173:1166-70.
78. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4:499-511.
79. Elsbach P. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J Leukoc Biol 1998; 64:14-8.
80. Weiss J. Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against Gram-negative bacteria. Biochem Soc Trans 2003; 31:785-90.
81. Wu A, Hinds CJ, Thiemermann C. High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock 2004; 21:210-21.
82. Kitchens RL, Thompson PA. Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteins. J Endotoxin Res 2003; 9:113-8.
83. Bennett-Guerrero E, Ayuso L, Hamilton-Davies C, et al. Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. JAMA 1997; 277:646-50.
84. Spitzer JH, Visintin A, Mazzoni A, Kennedy MN, Segal DM. Toll-like receptor 1 inhibits Toll-like receptor 4 signaling in endothelial cells. Eur J Immunol 2002; 32:1182-7.
85. Brint EK, Xu D, Liu H, et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol 2004; 5:373-9.
86. Li T, Hu J, Li L. Characterization of Tollip protein upon lipopolysaccharide challenge. Mol Immunol 2004; 41:85-92.
87. Chuang TH, Ulevitch RJ. Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors. Nat Immunol 2004; 5:495-502.
88. Yang KK, Dorner BG, Merkel U, et al. Neutrophil influx in response to a peritoneal infection with Salmonella is delayed in lipopolysaccharide-binding protein or CD14-deficient mice. J Immunol 2002; 169:4475-80.
89. Jack RS, Fan X, Bernheiden M, et al. Lipopolysaccharide binding protein is required to combat a murine Gram-negative infection. Nature 1997; 389:742-53.
90. Knapp S, de Vos AR Florquin S, Golenbock DT, van der Poll T. Lipopolysaccharide binding protein is an essential component of the innate immune response to Escherichia coli peritonitis in mice. Infect Immun 2003; 71:6747-53.
91. Le Roy D, Di Padova F, Adachi Y, Glauser MP, Calandra T, Heumann D. Critical role of lipopolysaccharide-binding protein and CD 14 in immune responses against gram-negative bacteria. J Immunol 2001; 167:2759-65.
92. Haziot A, Ferrero E, Kontgen F, et al. Resistance to endotoxin shock and reduced dissemination of Gram negative bacteria in CD14-deficient mice. Immunity 1996; 4:407-14.
93. Heumann D, Lauener R, Ryffel B. The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds. J Endotoxin Res 2003; 9:381-4.
94. Vazquez-Torres A, Vallance BA, Bergman MA, et al. Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network. J Immunol 2004; 172:6202-8.
95. Branger J, Knapp S, Weijer S, et al. Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect Immun 2004; 72:788-94.
96. Netea MG, Van Der Graaf CA, Vonk AG, Verscheueren I, van der Meer JW, Kullberg BJ. The role of Toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J Infect Dis 2002; 185:1483-9.
97. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118:229-41.
98. Nazli A, Yang PC, Jury J, et al. Epithelia under metabolic stress perceive commensal bacteria as a threat. Am J Pathol 2004; 164:947-57.
99. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature 2000; 407:784-8.
100. Watson RWG, Redmond HP, Wang JH, Condron C, Bouchier-Hays D. Neutrophils undergo apoptosis following ingestion of Escherichia coli. J Immunol 1996; 156:3986-92.
101. Rotstein D, Parodo J, Taneja R, Marshall JC. Phagocytosis of Candida albicans induces apoptosis of human neutrophils. Shock 2000; 14:278-83.
102. Sookhai S, Wang JJ, McCourt M, Kirwan W, Bouchier-Hayes D, Redmond HP. A novel therapeutic strategy for attenuating neutrophil-mediated lung injury in vivo. Ann Surg 2002; 235:285-91.
103. McCloskey RV, Straube RC, Sanders C, Smith SM, Smith CR, the CHESS Trial Study Group. Treatment of septic shock with human monoclonal antibody HA-1A: a randomized double-blind, placebo-controlled trial. Ann Intern Med 1994; 121:1-5.
104. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000; 162:505-11.
105. Fagon JY, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial. Ann Intern Med 2000; 132:621-30.